BioCheetah announces exclusive licensing and commercialisation agreement with Nippon Kayaku for VECanDx in Japan

Dec 15, 2023

Singapore/ Tokyo [Japan], December 15: BioCheetah Pte. Ltd. (Head Office: Singapore; CEO: Dr. Lee Kian Chung; hereinafter "BioCheetah") and Nippon Kayaku Co., Ltd. (Head...